EFFECTS OF FULL D-1 DOPAMINE-RECEPTOR AGONISTS ON FIRING RATES IN THEGLOBUS-PALLIDUS AND SUBSTANTIA-NIGRA PARS COMPACTA IN-VIVO - TESTS FOR D-1 RECEPTOR SELECTIVITY AND COMPARISONS TO THE PARTIAL AGONIST SKF-38393
Dn. Ruskin et al., EFFECTS OF FULL D-1 DOPAMINE-RECEPTOR AGONISTS ON FIRING RATES IN THEGLOBUS-PALLIDUS AND SUBSTANTIA-NIGRA PARS COMPACTA IN-VIVO - TESTS FOR D-1 RECEPTOR SELECTIVITY AND COMPARISONS TO THE PARTIAL AGONIST SKF-38393, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 272-281
Many studies have used the D-1 agonist SKF 38393 to characterize D-1 r
eceptor influences on firing rates in basal ganglia nuclei in vivo. Ho
wever, SKF 38393 is a partial agonist and so may not be ideal for deli
neating D-1 receptor effects. This study characterizes the effects of
four full D-1 agonists, SKF 82958 (chloro-APB), SKF 81297 (6-chloro-PB
), dihydrexidine and A-77636, on the firing rates of midbrain dopamine
and globus pallidus neurons. Recordings were done in fully anesthetiz
ed or paralyzed, locally anesthetized rats, and drugs were given syste
mically intravenously. Dihydrexidine, SKF 81297 and A-77636 were free
of rate effects on midbrain dopamine neurons (up to 10.2 mg/kg) and al
so did not antagonize the inhibitory effects of quinpirole. In contras
t, SKF 82958 strongly inhibited dopamine cells through activation of D
-2 autoreceptors (ED50 = 0.70 mg/kg). Of these drugs, SKF 82958 also w
as the only one to increase pallidal unit firing rates when given alon
e (at 5.0 but not 1.0 mg/kg); the other compounds appeared to be selec
tive for postsynaptic D-1 receptors. The results suggest that SKF 8295
8 may be more properly classified as a mixed D-1/D-2 agonist. In addit
ion, all four agonists strongly potentiated the pallidal response to q
uinpirole, demonstrating a D-1 receptor potentiation of D-2 receptor e
ffects. The results support the role of D-1 receptors in the midbrain
and globus pallidus as previously characterized with SKF 38393. The si
milar actions of partial and full D-1 agonists in these systems suppor
t evidence for a D-1 receptor reserve and possibly an effector system
other than adenylate cyclase.